ArticleOdontology2026
Can thermal cycling and iron supplement exposure alter the esthetic performance of bioactive dental materials?
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An in vitro comparison of color stability between alkasite and different restorative materials in various staining solutions.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to evaluate the color stability of contemporary bioactive restorative materials, including Equia Forte HT, GC Fuji II LC, ACTIVA BioACTIVE, Cention N, and a conventional composite resin, and to comparatively analyze their color changes following thermal aging and exposure to iron preparations. A total of 120 specimens were fabricated from five different restorative materials: Equia Forte, Cention N, ACTIVA BioACTIVE, Fuji II, and SolareX (n = 24 per group). All samples were initially subjected to thermal cycling, followed by immersion in two iron-containing solutions (Ferrum and Ocean) and one control solution (distilled water) for 72 h. Measurements were recorded at baseline (after 24 h of immersion in distilled water), after thermal cycling, and following staining procedures. Color difference (ΔE00) and lightness (L*) values were quantitatively assessed using a dental spectrophotometer based on the CIEDE2000 color evaluation system. Statistical analyses were performed using the Shapiro-Wilk test, Kruskal-Wallis test, and generalized linear models (GLM) approach. All analyses were conducted with SPSS version 22.0, with a significance level set at p < 0.05. A statistically significant difference was observed between the baseline and post-aging color values (p < 0.05). Among the materials tested, Equia Forte exhibited the greatest degree of color change, while ACTIVA BioACTIVE and SolareX demonstrated similar and comparatively lower levels of discoloration. Although no statistically significant difference was found between ACTIVA BioACTIVE and SolareX regarding total color change from baseline to final measurements (p > 0.05), the ΔE2 values of Equia Forte, Cention N, and Fuji II were significantly higher than those of the SolareX group (p < 0.05). Furthermore, significant differences were noted in the L* values before and after aging depending on the restorative material used (p < 0.05). Equia Forte showed the lowest L* values at both baseline (L1) and post-aging (L2), whereas ACTIVA BioACTIVE and SolareX presented the highest values. The findings of this in vitro study suggest that the color stability of restorative materials is influenced by intrinsic material properties as well as exposure to thermal aging and staining solutions. These factors should be considered when selecting restorative materials, particularly in esthetically demanding clinical situations.
Indexed as
Identifiers
41912967What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.